Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 02, 2026
TickeronGET DAILY SIGNALS
KB Home (KBH) vs LGI Homes (LGIH): Which Homebuilder Shows More Resilience Right Now?

KB Home (KBH) vs LGI Homes (LGIH): Which Homebuilder Shows More Resilience Right Now?

Key Takeaways

  • Tickeron AI Verdict: LGIH is the favored ticker of the two, based on stronger recent order trends, upwardly revised guidance, and more favorable analyst sentiment relative to KBH.
  • Both companies are U.S. homebuilders facing elevated mortgage rates and affordability pressure, but they serve different customer segments and growth strategies.
  • KBH is shifting toward a built-to-order model and has posted declining deliveries and gross margins in recent quarters.
  • LGIH has reported rising monthly home closings, raised its average selling price and margin guidance, and carries an "Overweight" consensus rating.
  • For deeper coverage, explore KBH Major News and KBH Today's Price Move, along with LGIH Major News and LGIH Today's Price Move.
  • To see how automated strategies are positioning across the market, explore the Trending AI Robots page.

Why Compare These Two Homebuilders?

Homebuilders sit at the intersection of interest rates, housing supply, and consumer confidence, making direct stock comparisons especially instructive for investors. This article examines KB Home (KBH) and LGI Homes (LGIH), two publicly traded U.S. homebuilders with distinct business models. Traders and investors tracking the housing cycle, relative performance, and market positioning may find this comparison useful for understanding how each company is navigating a softer demand environment. By reviewing recent market activity, earnings trends, and analyst sentiment, readers can better assess which of these two stocks currently presents the more compelling risk-reward profile. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.

KB Home's Position and Recent Challenges

KB Home, headquartered in Los Angeles and listed on the NYSE, is a diversified homebuilder serving first-time, move-up, and active adult buyers across states including California, Florida, Texas, and Arizona. The company has been strategically pivoting toward a built-to-order model, which now represents roughly three-quarters of deliveries and has reduced average build times.

In recent quarters, KBH has faced meaningful headwinds. Revenue has declined about 20% year over year in recent reporting periods, while housing gross margin has compressed amid pricing pressure, higher relative land costs, and rising input costs tied to tariffs. Net income has fallen sharply, and quarterly earnings growth has turned negative. Management has cited elevated mortgage rates, affordability challenges, and weak consumer confidence as factors weighing on traffic conversion. Despite these pressures, the company has maintained a quarterly dividend yielding roughly 2%, and analysts hold a consensus "Hold" rating with several firms lowering price targets in recent weeks. The stock has traded well below its 52-week high, reflecting cautious sentiment.

LGI Homes' Momentum and Strategy

LGI Homes, based in The Woodlands, Texas and listed on the Nasdaq, focuses on entry-level single-family homes marketed primarily to first-time and value-oriented buyers. The company also operates the Terrata Homes luxury brand and maintains a wholesale segment that sells homes in bulk to institutions building single-family rental portfolios.

In recent months, LGIH has shown improving operational momentum. The company reported year-over-year increases in monthly home closings through late 2026, including a roughly 9% gain in September and a double-digit rise in third-quarter closings. In its most recent quarterly report, earnings came in ahead of consensus, and management raised full-year guidance for average selling price and homebuilding gross margin. Revenue remains lower than prior-year levels, and net income has declined from cyclical highs, but the company has maintained a deleveraging trend and a strong backlog. Analyst coverage leans positive, with an "Overweight" consensus and price targets substantially above the current share price. The stock carries a higher beta than peers, indicating greater volatility. I ran a quick check on Tickeron’s AI Daily Buy/Sell Signals to confirm the recent momentum patterns.

How the Two Compare Head-to-Head

The two companies differ most clearly in customer focus and near-term trajectory. KBH serves a broader buyer base and is undergoing a structural transition toward built-to-order, a shift that has temporarily pressured deliveries and margins but may improve long-term capital efficiency. LGIH, by contrast, targets the entry-level segment and benefits from a growing institutional wholesale channel, while actively raising guidance in recent quarters.

On relative performance, LGIH has shown steadier sequential improvement in closings and margin outlook, whereas KBH has seen earnings estimates revised lower. Risk profiles also differ: LGIH has a higher beta and more concentrated exposure to the entry-level segment, while KBH offers a dividend and greater geographic diversification. From a valuation standpoint, KBH trades at a lower price-to-book ratio, while LGIH carries a higher forward earnings multiple that reflects stronger expected growth.

Tickeron AI Verdict

Based on observable factors, Tickeron's AI would likely favor LGIH in the current environment. The company's rising closings, upwardly revised selling price and margin guidance, and more constructive analyst posture suggest a more consistent near-term trend than KBH, whose earnings momentum and margin trajectory have been under pressure during its built-to-order transition. While KBH retains strengths in diversification and income, its relative positioning appears less favorable on trend consistency and catalysts. This assessment is probabilistic and based on currently available data, not a definitive prediction of future performance.

Incorporating AI Tools Into My Research Process

When preparing analyses like this one, I often turn to Tickeron’s AI Trading Bots to test how different automated strategies might align with the trends I’m seeing in individual names. The platform lets users review performance across various timeframes and approaches, which adds a useful layer of perspective when weighing relative opportunities in sectors like housing. It has become a regular part of how I cross-check signals before forming a final view.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: KBH, LGIH

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


KBH's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for KBH turned positive on October 16, 2026. Looking at past instances where KBH's MACD turned positive, the stock continued to rise in 37 of 51 cases over the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on KBH as a result. In 60 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

KBH moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where KBH advanced for three days, in 207 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

KBH broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for KBH entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.811) is normal, around the industry mean (1.847). P/E Ratio (12.062) is within average values for comparable stocks, (10.066). Projected Growth (PEG Ratio) (0.280) is also within normal values, averaging (1.217). Dividend Yield (0.020) settles around the average of (0.019) among similar stocks. P/S Ratio (0.573) is also within normal values, averaging (24.205).

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. KBH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock worse than average.

The Tickeron SMR rating for this company is 79 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are DR Horton (NYSE:DHI), Pultegroup (NYSE:PHM), Lennar Corp (NYSE:LEN), KB Home (NYSE:KBH).

Industry description

Homebuilding includes companies residential home construction companies, renovators and repair firms. The companies may be building single-family or multifamily homes, condominiums or mobile homes. Over the five years to 2019, the Home Builders industry is estimated to have grown at an annualized rate of 2.5% to reach $89.4 billion, (including expected growth of 2.6% in 2019), according to a study by IbisWorld. After having suffered one of its worst crises a decade ago during the last macroeconomic recession–which had much of its origins in U.S. real estate – the homebuilding industry has been recovering steadily so far. Higher disposable incomes and improving economic activity have bolstered consumers’ purchases of homes. While revenue of the Home Builders industry remains well below its prerecession high, demand growth estimates show promise.

Market Cap

The average market capitalization across the Homebuilding Industry is 7.8B. The market cap for tickers in the group ranges from 12.75K to 42.77B. DHI holds the highest valuation in this group at 42.77B. The lowest valued company is BDCC at 12.75K.

High and low price notable news

The average weekly price growth across all stocks in the Homebuilding Industry was 6%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 5%. CVCO experienced the highest price growth at 25%, while BXBL experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Homebuilding Industry was 32%. For the same stocks of the Industry, the average monthly volume growth was 8% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 31
Price Growth Rating: 58
SMR Rating: 71
Profit Risk Rating: 65
Seasonality Score: 57 (-100 ... +100)
View a ticker or compare two or three
KBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a constructor and seller single family homes as well as condominium complexes

Industry Homebuilding

Industry
Homebuilding
Address
10990 Wilshire Boulevard
Phone
+1 310 231-4000
Employees
2384
Web
https://www.kbhome.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Shares of Brookfield Infrastructure Corporation (BIPC) are down approximately 11% on Wednesday, trading near $35.44 after closing at $39.82 on April 28, following the release of Q1 2026 earnings before the market open. Primary catalyst: Q1 2026 results showed a GAAP net loss of $61 million, a sharp reversal from net income of $125 million in Q1 2025 — a $186 million year-over-year deterioration.
Shares of Regeneron Pharmaceuticals (REGN) are down approximately 6% on Wednesday, trading near $688 after closing at $731.77 on April 28, in an earnings-driven selloff despite a headline beat on both EPS and revenue. Primary catalyst: A sharp "beat and sell" market reaction driven by the continued deterioration of the core EYLEA franchise — total U.S. EYLEA HD and EYLEA net sales declined 10% year-over-year to $941 million, more than offsetting record Dupixent growth.